Research classified by Journal of Economic Literature (JEL) codes

2007

• Finn Valentin & Rasmus Jensen, 2007, "Effects on academia-industry collaboration of extending university property rights," The Journal of Technology Transfer, Springer, volume 32, issue 3, pages 251-276, June, DOI: 10.1007/s10961-006-9015-x.
• Paul Grootendorst, 2007, "Effects of 'Authorized-Generics' on Canadian Drug Prices," Social and Economic Dimensions of an Aging Population Research Papers, McMaster University, number 201, Jun.
• Glenn Ellison & Sara Fisher Ellison, 2007, "Strategic Entry Deterrence and the Behavior of Pharmaceutical Incumbents Prior to Patent Expiration," NBER Working Papers, National Bureau of Economic Research, Inc, number 13069, Apr.
• Joseph H. Golec & John A. Vernon, 2007, "Financial Risk in the Biotechnology Industry," NBER Working Papers, National Bureau of Economic Research, Inc, number 13604, Nov.
• Olivier Cadot & Jaime de Melo, 2007, "Why OECD Countries Should Reform Rules of Origin," The World Bank Research Observer, World Bank, volume 23, issue 1, pages 77-105, October.
• Kitsak, Maksim & Havlin, Shlomo & Paul, Gerald & Riccaboni, Massimo & Pammolli, Fabio & Stanley, H. Eugene, 2007, "Betweenness Centrality of Fractal and Non-Fractal Scale-Free Model Networks and Tests on Real Networks," MPRA Paper, University Library of Munich, Germany, number 15907, May.
• Bergmann, Manfred & Schmitz, Andreas & Hayden, Mark & Kosonen, Katri, 2007, "Imposing a unilateral carbon constraint on European energy-intensive industries and its impact on their international competitiveness - data & analysis," MPRA Paper, University Library of Munich, Germany, number 9563, Dec.
• Hermans, Raine & Kulvik, Martti, 2007, "Simulaatio lääkekehitysalan kannattavuudesta ja riskeistä," Discussion Papers, The Research Institute of the Finnish Economy, number 1075.
• Stefano Brusoni, 2007, "Managing the Uneven Evolution of Know-How. Engineering Design as "Social technology"," European Journal of Economic and Social Systems, Lavoisier, volume 20, issue 2, pages 147-162.
• Antoine Bureth & Julien Pénin, 2007, "Modular Innovations and Distributed Processes. The Case of Genetically Engineered Vaccines," European Journal of Economic and Social Systems, Lavoisier, volume 20, issue 2, pages 251-273.
• Sonja Kind & Dodo zu Knyphausen-Aufseß, 2007, "What is "Business Development"? - The Case of Biotechnology," Schmalenbach Business Review (sbr), LMU Munich School of Management, volume 59, issue 2, pages 176-199, April.
• Marina Geenhuizen, 2007, "Modelling dynamics of knowledge networks and local connectedness: a case study of urban high-tech companies in The Netherlands," The Annals of Regional Science, Springer;Western Regional Science Association, volume 41, issue 4, pages 813-833, December, DOI: 10.1007/s00168-007-0143-5.
• Sergey V. Buldyrev & Jakub Growiec & Fabio Pammolli & Massimo Riccaboni & H. Eugene Stanley, 2007, "The Growth of Business Firms: Facts and Theory," Journal of the European Economic Association, MIT Press, volume 5, issue 2-3, pages 574-584, 04-05.
• Claudio Bravo-Ortega & Manuel Agosin Trumper, 2007, "The Emergence Of New Successful Export Activities In Latin America: The Case Of Chile," Working Papers, University of Chile, Department of Economics, number wp236, Apr.
• Michele Snoeck & Carlos Casacuberta & Rosario Domingo & Héctor Pastori & Lucía Pittaluga, 2007, "The Emergence of new Successful Export Activities in Uruguay," Documentos de Trabajo (working papers), Department of Economics - dECON, number 0908, Dec.
• Antoine Bureth & Moritz Mueller & Julien Pénin & Sandrine Wolff, 2007, "Brevet, innovation modulaire et collaboration : Le cas des vaccins géniques," Working Papers of BETA, Bureau d'Economie Théorique et Appliquée, UDS, Strasbourg, number 2007-22.
• Iván Moreno Torres & Jaume Puig & Joan-Ramon Borrell-Arqué, 2007, "Generic entry into a regulated pharmaceutical market," Economics Working Papers, Department of Economics and Business, Universitat Pompeu Fabra, number 1014, Feb.
• Antonio Cabrales & Sergi Jiménez-Martín, 2007, "The determinants of pricing in pharmaceuticals: Are U.S. prices really higher than those of Canada?," Economics Working Papers, Department of Economics and Business, Universitat Pompeu Fabra, number 1032, Apr.
• Javier Coronado & Sergi Jiménez-Martín & Pedro L. Marín, 2007, "Multimarket contact in pharmaceutical markets," Economics Working Papers, Department of Economics and Business, Universitat Pompeu Fabra, number 1033, Apr, revised Jul 2007.
• Iván Moreno Torres & Jaume Puig & Joan-Ramon Borrell-Arqué, 2007, "Generic entry into a regulated pharmaceutical market," Working Papers, Research Center on Health and Economics, Department of Economics and Business, Universitat Pompeu Fabra, number 1014, Feb.
• Edward Christie & Gabor Hunya & Waltraut Urban, 2007, "Restructuring of Energy-intensive Industrial Branches in Romania and Proposals for Industrial Policy Measures," wiiw Research Reports, The Vienna Institute for International Economic Studies, wiiw, number 339, Apr.
• David Reiffen & Michael R. Ward, 2007, "'Branded Generics' as a strategy to limit cannibalization of pharmaceutical markets," Managerial and Decision Economics, John Wiley & Sons, Ltd., volume 28, issue 4-5, pages 251-265, DOI: 10.1002/mde.1339.
• Frank R. Lichtenberg & Suchin Virabhak, 2007, "Pharmaceutical-embodied technical progress, longevity, and quality of life: drugs as 'Equipment for Your Health'," Managerial and Decision Economics, John Wiley & Sons, Ltd., volume 28, issue 4-5, pages 371-392, DOI: 10.1002/mde.1347.
• Frank R. Lichtenberg, 2007, "Benefits and costs of newer drugs: an update," Managerial and Decision Economics, John Wiley & Sons, Ltd., volume 28, issue 4-5, pages 485-490, DOI: 10.1002/mde.1355.
• Czarnitzki, Dirk & Toole, Andrew A., 2007, "Exploring the relationship between scientist human capital and firm performance: The case of biomedical academic entrepreneurs in the SBIR program," ZEW Discussion Papers, ZEW - Leibniz Centre for European Economic Research, number 07-011.

2006

• Finn Valentin & Henrich Dahlgren & Rasmus Lund Jensen, 2006, "Research Strategies in Science-based Start-ups - Effects on performance in Danish and Swedish biotechnology," DRUID Working Papers, DRUID, Copenhagen Business School, Department of Industrial Economics and Strategy/Aalborg University, Department of Business Studies, number 06-11.
• Daron Acemoglu & David Cutler & Amy Finkelstein & Joshua Linn, 2006, "Did Medicare Induce Pharmaceutical Innovation?," American Economic Review, American Economic Association, volume 96, issue 2, pages 103-107, May, DOI: 10.1257/000282806777211766.
• S. V. Buldyrev & F. Pammolli & M. Riccaboni & K. Yamasaki & D. Fu & K. Matia & H. E. Stanley, 2006, "A Generalized Preferential Attachment Model for Business Firms Growth Rates: II. Mathematical Treatment," Papers, arXiv.org, number physics/0609020, Sep.
• Aoki, Reiko & Kubo, Kensuke & Yamane, Hiroko, 2006, "Indian Patent Policy and Public Health:Implications from the Japanese Experience," Working Papers, Department of Economics, The University of Auckland, number 199.
• Steven Klepper, 2006, "The Evolution of Geographic Structure in New Industries," Revue de l'OFCE, Presses de Sciences-Po, volume 97, issue 5, pages 135-158.
• Thomas Grebel & Jackie Krafft & Pier-Paolo Saviotti, 2006, "On the Life Cycle of Knowledge Intensive Sectors," Revue de l'OFCE, Presses de Sciences-Po, volume 97, issue 5, pages 63-85.
• Franco Malerba & Luigi Orsenigo & Sandrine Selosse, 2006, "Biotechnologies et industrie pharmaceutique. Un modèle évolutionnaire conforme à l'histoire," Revue de l'OFCE, Presses de Sciences-Po, volume 96, issue 1, pages 157-209.
• Lionel Nesta & Pier-Paolo Saviotti, 2006, "Intégration technologique et valeur boursière des firmes de biotechnologies," Revue de l'OFCE, Presses de Sciences-Po, volume 96, issue 1, pages 211-233.
• Paul Belleflamme & Tanguy van Ypersele, 2006, "Comment favoriser l'innovation dans le secteur pharmaceutique : brevets et/ou récompenses ?," Reflets et perspectives de la vie économique, De Boeck Université, volume 0, issue 4, pages 23-35.
• Michel Trommetter, 2006, "La propriété intellectuelle dans les biotechnologies agricoles : quels enjeux pour quelles perspectives ?," Reflets et perspectives de la vie économique, De Boeck Université, volume 0, issue 4, pages 37-48.
• Kurt R. Brekke & Ingrid Königbauer & Odd Rune Straume, 2006, "Reference Pricing of Pharmaceuticals," CESifo Working Paper Series, CESifo, number 1825.
• Emilio Archila & Gabriel Carrasquilla & Marcela Mel�ndez & Juan Pablo Uribe, 2006, "Estudio sobre la propiedad intelectual en el sector farmacéutico colombiano," Informes de Investigación, Fedesarrollo, number 2622, Mar.
• Emilio J. Archila & Gabriel Carrasquilla & Marcela Mel�ndez & Juan Pablo Uribe, 2006, "Estudio sobre la propiedad intelectual en el sector farmacéutico colombiano," Cuadernos de Fedesarrollo, Fedesarrollo, number 12708, Mar.
• Genesove, David, 2006, "The Dye Famine and its Aftermath: Knowledge Diffusion and Entry," CEPR Discussion Papers, C.E.P.R. Discussion Papers, number 5890, Oct.
• Oleg Badunenko & Michael Fritsch & Andreas Stephan, 2006, "Allocative Efficiency Measurement Revisited: Do We Really Need Input Prices?," Discussion Papers of DIW Berlin, DIW Berlin, German Institute for Economic Research, number 591.
• Annika Bergman, 2006, "FDI and Spillover Effects in the Indian Pharmaceutical Industry," Finance Working Papers, East Asian Bureau of Economic Research, number 22084, Jan.
• Brekke, Kurt R. & Kuhn, Michael, 2006, "Direct to consumer advertising in pharmaceutical markets," Journal of Health Economics, Elsevier, volume 25, issue 1, pages 102-130, January.
• Céline Carrere & Olivier Cadot, 2006, "Are different Rules of Origin Equally Costly? Estimates from NAFTA," Post-Print, HAL, number hal-00130079.
• Antoine Bureth & Rachel Levy & Julien Pénin & Sandrine Wolff, 2006, "Strategic Reasons for Patenting : Between Exclusion and Coordination Rationales," Post-Print, HAL, number hal-00279139.
• Marc-Hubert Depret & Abdelillah Hamdouch, 2006, "La gouvernance des jeunes entreprises innovantes : Un éclairage analytique a partir du cas des sociétés de biotechnologies," Post-Print, HAL, number hal-00279284.
• Michel Trommetter, 2006, "La proprieté intellectuelle dans les biotechnologies agricoles : Quels enjeux pour quelles perspectives ?," Working Papers, HAL, number hal-00243036.
• Brekke, Kurt R. & Grasdal, Astrid L. & Holmås, Tor Helge, 2006, "Regulation and Pricing of Pharmaceuticals: Reference Pricing or Price Cap Regulation?," Working Papers in Economics, University of Bergen, Department of Economics, number 14/06, Sep.
• Eliasson, Gunnar & Eliasson, Åsa, 2006, "The Pharmacia Story of Entrepreneurship and as a Creative Technical University - An Experiment in Innovation, Organizational Break Up and Industrial Renaissance," Ratio Working Papers, The Ratio Institute, number 97, May.
• Acemoglu, Daron & Finkelstein, Amy & Cutler, David & Linn, Joshua, 2006, "Did Medicare Induce Pharmaceutical Innovation?," Scholarly Articles, Harvard University Department of Economics, number 2664267.
• Aoki, Reiko & Kubo, Kensuke & Yamane, Hiroko, 2006, "Indian Patent Policy and Publich Health : implications from the Japanese Experience," IDE Discussion Papers, Institute of Developing Economies, Japan External Trade Organization(JETRO), number 57, Mar.
• Jörg Mahlich & Thomas Roediger-Schluga, 2006, "The Determinants of Pharmaceutical R&D Expenditures: Evidence from Japan," Review of Industrial Organization, Springer;The Industrial Organization Society, volume 28, issue 2, pages 145-164, March, DOI: 10.1007/s11151-006-0010-z.
• Helga De Doncker, 2006, "R&D in the Belgian Pharmaceutical Sector," Working Paper Document, National Bank of Belgium, number 106, Dec.
• Daron Acemoglu & David Cutler & Amy Finkelstein & Joshua Linn, 2006, "Did Medicare Induce Pharmaceutical Innovation?," NBER Working Papers, National Bureau of Economic Research, Inc, number 11949, Jan.
• Beata Smarzynska Javorcik & Wolfgang Keller & James R. Tybout, 2006, "Openness and Industrial Responses in a Wal-Mart World: A Case Study of Mexican Soaps, Detergents and Surfactant Producers," NBER Working Papers, National Bureau of Economic Research, Inc, number 12457, Aug.
• Jeffrey L. Furman & Margaret K. Kyle & Iain M. Cockburn & Rebecca Henderson, 2006, "Public & Private Spillovers, Location and the Productivity of Pharmaceutical Research," NBER Working Papers, National Bureau of Economic Research, Inc, number 12509, Sep.
• Pradhan, Jaya Prakash & Alakshendra, Abhinav, 2006, "Overseas Acquisition versus Greenfield Foreign Investment: Which Internationalization Strategy is better for Indian Pharmaceutical Enterprises?," MPRA Paper, University Library of Munich, Germany, number 12339, Aug.
• Pradhan, Jaya Prakash, 2006, "Global Competitiveness of Indian Pharmaceutical Industry: Trends and Strategies," MPRA Paper, University Library of Munich, Germany, number 12340, Jun.
• Buldyrev, Sergey V. & Pammolli, Fabio & Riccaboni, Massimo & Yamasaki, Kazuko & Fu, Dongfeng & Matia, Kaushik & Stanley, H. Eugene, 2006, "A Generalized Preferential Attachment Model for Business Firms Growth Rates: II. Mathematical Treatment," MPRA Paper, University Library of Munich, Germany, number 15980, Aug.
• Pammolli, Fabio & Fu, Dongfeng & Buldyrev, Sergey V. & Riccaboni, Massimo & Matia, Kaushik & Yamasaki, Kazuko & Stanley, H. Eugene, 2006, "A Generalized Preferential Attachment Model for Business Firms Growth Rates: I. Empirical Evidence," MPRA Paper, University Library of Munich, Germany, number 15983, Aug.
• Havas, Attila, 2006, "Private Sector R&D in the New Member States: Hungary," MPRA Paper, University Library of Munich, Germany, number 55786, Oct.
• Hernesniemi, Hannu & Kulvik, Martti, 2006, "Helsingin seudun klusterit sekä erikoistuminen bioteknologiaan ja logistiikkaan," Discussion Papers, The Research Institute of the Finnish Economy, number 1013.
• Maunula, Mari, 2006, "The Perceived Value-added of Venture Capital Investors. Evidence from Finnish Biotechnology Industry," Discussion Papers, The Research Institute of the Finnish Economy, number 1030.
• Terttu Luukkonen, & Mari Maunula,, 2006, "Coaching Small Biotech Companies into Success: The Value-adding Function of VC," Discussion Papers, The Research Institute of the Finnish Economy, number 1032.
• Kulvik, Martti & Linnosmaa, Ismo & Hermans, Raine, 2006, "Adaption of New Technologies and Costs of Health Care," Discussion Papers, The Research Institute of the Finnish Economy, number 1037.
• Luukkonen, Terttu & Maunula, Mari, 2006, "Riskirahoituksen merkitys biotekniikka-alalla: Pääomasijoittajien vertailu yritysten näkökulmasta," Discussion Papers, The Research Institute of the Finnish Economy, number 1057.
• Jaya Prakash Pradhan, 2006, "Global competitiveness of Indian Pharmaceutical Industry: Trends and Strategies," Working Papers, Institute for Studies in Industrial Development (ISID), number 095, Jun.
• Jaya Prakash Pradhan & Abhinav Alakshendra, 2006, "Overseas Acquisition Versus Greenfield Foreign Investment: Which Internationalization Strategy is better for Indian Pharmaceutical Enterprises?," Working Papers, Institute for Studies in Industrial Development (ISID), number 097, Aug.
• Isamel Rafols & Martin Meyer, 2006, "Knowledge-sourcing strategies for cross-disciplinarity in bionanotechnology," SPRU Working Paper Series, SPRU - Science Policy Research Unit, University of Sussex Business School, number 152, Jul.
• Gehl Sampath, Padmashree, 2006, "Breaking the Fence: Patent Rights and Biomedical Innovation in 'Technology Followers'," MERIT Working Papers, United Nations University - Maastricht Economic and Social Research Institute on Innovation and Technology (MERIT), number 2006-008.
• Mahlich, Jörg C. & Roediger-Schluga, Thomas, 2006, "The Determinants of Pharmaceutical R&D Expenditures: Evidence from Japan," MERIT Working Papers, United Nations University - Maastricht Economic and Social Research Institute on Innovation and Technology (MERIT), number 2006-015.
• Gehl Sampath, Padmashree, 2006, "India's product patent protection regime: Less or more of "pills for the poor"?," MERIT Working Papers, United Nations University - Maastricht Economic and Social Research Institute on Innovation and Technology (MERIT), number 2006-019.
• Oyelaran-Oyeyinka, Banji & Gehl Sampath, Padmashree, 2006, "Rough Road to Market: Institutional Barriers to Innovations in Africa," MERIT Working Papers, United Nations University - Maastricht Economic and Social Research Institute on Innovation and Technology (MERIT), number 2006-026.
• Gehl Sampath, Padmashree, 2006, "Indian Pharma Within Global Reach?," MERIT Working Papers, United Nations University - Maastricht Economic and Social Research Institute on Innovation and Technology (MERIT), number 2006-031.
• Gourdon, Julien & Maystre, Nicolas & de Melo, Jaime, 2006, "Openness, inequality, and poverty : endowments matter," Policy Research Working Paper Series, The World Bank, number 3981, Aug.
• Javorcik, Beata & Keller, Wolfgang & Tybout, James, 2006, "Openness and industrial response in a Wal-Mart world : a case study of Mexican soaps, detergents, and surfactant producers," Policy Research Working Paper Series, The World Bank, number 3999, Aug.
• Grether, Jean-Marie & Mathys, Nicole A. & de Melo, Jaime, 2006, "Unraveling the worldwide pollution haven effect," Policy Research Working Paper Series, The World Bank, number 4047, Nov.
• Badunenko, Oleg & Fritsch, Michael & Stephan, Andreas, 2006, "Allocative efficiency measurement revisited: Do we really need input prices?," Working Paper Series, European University Viadrina Frankfurt (Oder), The Postgraduate Research Programme Capital Markets and Finance in the Enlarged Europe, number 2006,7.
• Neunteufel, Herbert & Rössel, Gottfried & Sassenberg, Uwe & Laske, Michael & Kipura, Janine & Brüning, Andreas, 2006, "Überwindung betriebswirtschaftlicher Defizite im Innoregio-Netzwerk Kunststoffzentrum Westmecklenburg," Wismar Discussion Papers, Hochschule Wismar, Wismar Business School, number 18/2006.
• Schudy, Simeon, 2006, "Jüngere Entwicklungen auf dem Risikokapitalmarkt für Biotechnologie in Deutschland," Kiel Working Papers, Kiel Institute for the World Economy, number 1270.
• Badunenko, Oleg & Fritsch, Michael & Stephan, Andreas, 2006, "Allocative efficiency measurement revisited: do we really need input prices?," Freiberg Working Papers, TU Bergakademie Freiberg, Faculty of Economics and Business Administration, number 2006/04.

2005

• Jeffrey Furman & Margaret K. Kyle & Alain Cockburn & Rebecca M. Henderson, 2005, "Public & Private Spillovers: Location and the Productivity of Pharmaceutical Research," Annals of Economics and Statistics, GENES, issue 79-80, pages 165-188.
• James, Harvey S., Jr., 2005, "Trust in Scientists and Food Manufacturers, with Implications for the Public Support of Biotechnology," Working Papers, University of Missouri Columbia, Department of Agricultural Economics, number 92649, Jul, DOI: 10.22004/ag.econ.92649.
• Dongfeng Fu & Fabio Pammolli & S. V. Buldyrev & Massimo Riccaboni & Kaushik Matia & Kazuko Yamasaki & H. E. Stanley, 2005, "The Growth of Business Firms: Theoretical Framework and Empirical Evidence," Papers, arXiv.org, number physics/0512005, Dec.
• Berndt Ernst R. & Gottschalk Adrian H. B. & Philipson Tomas & Strobeck Matthew W., 2005, "Assessing the Impacts of the Prescription Drug User Fee Acts (PDUFA) on the FDA Approval Process," Forum for Health Economics & Policy, De Gruyter, volume 8, issue 1, pages 1-25, January, DOI: 10.2202/1558-9544.1013.
• Ma. Teresa Dueñas-Caparas, 2005, "State of Competition in the Wholesale and Retail Sector," Development Economics Working Papers, East Asian Bureau of Economic Research, number 22630, Jan.
• Sachin Chaturvedi & Lian Chawii, 2005, "Biosafety Protocol, International Trade and Agricultural Biotechnology : Policy Inferences for India," Trade Working Papers, East Asian Bureau of Economic Research, number 22086, Jan.
• Wuyts, Stefan & Colombo, Massimo G. & Dutta, Shantanu & Nooteboom, Bart, 2005, "Empirical tests of optimal cognitive distance," Journal of Economic Behavior & Organization, Elsevier, volume 58, issue 2, pages 277-302, October.
• Lionel Nesta, 2005, "Knowledge and Productivity in the World's Largest Manufacturing Corporations Level:Panel Data analysis on Compustat and Patent data," Documents de Travail de l'OFCE, Observatoire Francais des Conjonctures Economiques (OFCE), number 2005-17.
• Avenel, E. & Corolleur, F. & Gauthier, C. & Rieu, C., 2005, "Start-ups, firm growth and the consolidation of the French biotech industry," Working Papers, Grenoble Applied Economics Laboratory (GAEL), number 200503.
• Izabela Jelovac & Catalina Bordoy, 2005, "Pricing and Welfare Implications of Parallel Imports in the Pharmaceutical Industry," Post-Print, HAL, number hal-03881154, DOI: 10.1007/s10754-005-6599-x.
• Nicolas Berland & Marie-Claire Loison, 2005, "" RESPONSIBLE CARE " ET MANAGEMENT DURABLE : COMPORTEMENT VOLONTAIRE OU RÉACTION ADAPTATIVE ? Généalogie et pratiques dans l'industrie chimique," Post-Print, HAL, number halshs-00581125, May.
• Brekke, Kurt R & Königbauer, Ingrid & Straume, Odd Rune, 2005, "Reference Pricing of Pharmaceuticals," Working Papers in Economics, University of Bergen, Department of Economics, number 19/05, Nov.
• Jacint Balaguer & Ezequiel Uriel Jiménez & Vicente Orts, 2005, "Testing Collusive Prices In A Multimarket Context: The European Case Of Vitamin C," Working Papers. Serie EC, Instituto Valenciano de Investigaciones Económicas, S.A. (Ivie), number 2005-06, Mar.
• Ito, Banri & Yamagata, Tatsufumi, 2005, "Who Develops Innovations in Medicine for the Poor? Trends in Patent Applications Related to Medicines for HIV/AIDS, Tuberculosis, Malaria and Neglected Diseases," IDE Discussion Papers, Institute of Developing Economies, Japan External Trade Organization(JETRO), number 24, Apr.
• Ken Tabata & Testuya Shinkai & Satoru Tanaka & Makoto Okamura, 2005, "Parallel Imports, Drag Price Control and Pharmaceutical Innovation," Discussion Paper Series, School of Economics, Kwansei Gakuin University, number 26, Aug, revised Aug 2005.
• David M. Cutler & Alan M. Garber, 2005, "Frontiers in Health Policy Research, Volume 8," NBER Books, National Bureau of Economic Research, Inc, number cutl05-1, January.
• Ernst R. Berndt & Adrian H. B. Gottschalk & Tomas Philipson & Matthew W. Strobeck, 2005, "Assessing the Impacts of the Prescription Drug User Fee Acts (PDUFA) on the FDA Approval Process," NBER Chapters, National Bureau of Economic Research, Inc, "Frontiers in Health Policy Research, Volume 8".
• Lynne G. Zucker & Michael R. Darby, 2005, "Socio-economic Impact of Nanoscale Science: Initial Results and NanoBank," NBER Working Papers, National Bureau of Economic Research, Inc, number 11181, Mar.
• Joseph Golec & Shantaram Hegde & John A. Vernon, 2005, "Pharmaceutical Stock Price Reactions to Price Constraint Threats and Firm-Level R&D Spending," NBER Working Papers, National Bureau of Economic Research, Inc, number 11229, Mar.
• Jean-François Brun & Céline Carrère & Patrick Guillaumont & Jaime de Melo, 2005, "Has Distance Died? Evidence from a Panel Gravity Model," The World Bank Economic Review, World Bank, volume 19, issue 1, pages 99-120.
• Fu, Dongfeng & Pammolli, Fabio & Buldyrev, Sergey V. & Riccaboni, Massimo & Matia, Kaushik & Yamasaki, Kazuko & Stanley, H. Eugene, 2005, "The Growth of Business Firms: Theoretical Framework and Empirical Evidence," MPRA Paper, University Library of Munich, Germany, number 15905.
• Shalendra D. Sharma, 2005, "Agricultural Development for Inclusive Growth: A Strategy for Achieving the Millennium Development Goals," East Asian Economic Review, Korea Institute for International Economic Policy, volume 9, issue 1, pages 59-84, DOI: 10.11644/KIEP.JEAI.2005.9.1.136.
• Antoine Bureth & Rachel Levy & Julien Pénin & Sandrine Wolff, 2005, "Strategic Reasons for Patenting: Between Exclusion and Coordination Rationales," Rivista di Politica Economica, SIPI Spa, volume 95, issue 5, pages 19-46, September.
• Jan Larsson & Kjetil Telle, 2005, "Consequences of the IPPC-directive's BAT requirements for abatement costs and emissions," Discussion Papers, Statistics Norway, Research Department, number 411, Mar.
• Stefano Brusoni & Paola Criscuolo & Aldo Geuna, 2005, "The knowledge bases of the world's largest pharmaceutical groups: what do patent citations to non-patent literature reveal?," Economics of Innovation and New Technology, Taylor & Francis Journals, volume 14, issue 5, pages 395-415, DOI: 10.1080/1043859042000307356.
• Philip Cooke & Nick Clifton, 2005, "Visionary, precautionary and constrained 'varieties of devolution' in the economic governance of the devolved UK territories," Regional Studies, Taylor & Francis Journals, volume 39, issue 4, pages 437-451, DOI: 10.1080/00343400500128457.
• Gilsing, V.A. & Nooteboom, B., 2005, "Density and Strength of Ties in Innovation Networks : An Analysis of Multi-Media and Biotechnology," Discussion Paper, Tilburg University, Center for Economic Research, number 2005-41.
• Wuyts, S.H.K. & Colombo, M. & Dutta, S. & Nooteboom, B., 2005, "Empirical Tests of Optimal Cognitive Distance," Discussion Paper, Tilburg University, Center for Economic Research, number 2005-45.
• Gilsing, V.A. & Nooteboom, B., 2005, "Density and Strength of Ties in Innovation Networks : An Analysis of Multi-Media and Biotechnology," Other publications TiSEM, Tilburg University, School of Economics and Management, number 778502fd-6813-4ba2-b746-f.
• David Reiffen & Michael R. Ward, 2005, "Generic Drug Industry Dynamics," The Review of Economics and Statistics, MIT Press, volume 87, issue 1, pages 37-49, February.
• Tınis Mets, 2005, "Innovation Paths of Estonian Biotechnology," Working Papers, Tallinn School of Economics and Business Administration, Tallinn University of Technology, number 131.
• Michael R. Ward & David Reiffen, 2005, "“Branded Generics” As A Strategy To Limit Cannibalization Of Pharmaceutical Markets," Working Papers, University of Texas at Arlington, Department of Economics, number 0502, May.
• Daniel Rais & Jonathan Goldman, 2005, "Phases of Imitation and Innovation in a North-South Endogenous Growth Model," Working Papers, University of Texas at Arlington, Department of Economics, number template, May.
• Xia Wang, 2005, "Technological Characteristics and R&D Alliance Form: Evidence from the U.S. Biotechnology Industry," Working papers, University of Connecticut, Department of Economics, number 2005-35, Aug.
• Marcello Basili & Roberto Renò & Carlo Zappia, 2005, "Production of a New Drug: A Sequential Investment ProcessUnder Uncertainty," Department of Economics University of Siena, Department of Economics, University of Siena, number 453, Jul.
• Alessandra CASTELLINI & Maurizio Canavari & Carlo Pirazzoli, 2005, "Functional Foods In The European Union: An Overview Of The Sector'S Main Issues," Others, University Library of Munich, Germany, number 0505004, May.
• Fier, Andreas & Heneric, Oliver, 2005, "Public R&D Policy: The Right Turns of the Wrong Screw? The Case of the German Biotechnology Industry," ZEW Discussion Papers, ZEW - Leibniz Centre for European Economic Research, number 05-60.
• Toole, Andrew A., 2005, "Does Public Scientific Research Complement Industry R&D Investment? The Case of NIH Supported Basic and Clinical Research and Pharmaceutical Industry R&D," ZEW Discussion Papers, ZEW - Leibniz Centre for European Economic Research, number 05-75.

2004

• Joan Ramon Borrell Arque, 2004, "Las patentes aceleran o retrasan la comercializacion de nuevos medicamentos en los paises en desarrollo?," Working Papers in Economics, Universitat de Barcelona. Espai de Recerca en Economia, number 122.
• Sophie-Hélène Bataïni, 2004, "L'interaction des dynamiques individuelles et collectives dans le processus de développement territorial," Revue d'économie régionale et urbaine, Armand Colin, volume 0, issue 5, pages 713-735.
• Céline CARRERE & Jaime MELO DE, 2004, "Are Different Rules of Origin Equally Costly? Estimates from NAFTA," Working Papers, CERDI, number 200412.
• Frank Lichtenberg, 2000, "The Benefits and Costs of Newer Drugs: Evidence from the 1996 Medical Expenditure Panel Survey," CESifo Working Paper Series, CESifo, number 404.
• Marc-Hubert Depret & Abdelillah Hamdouch, 2004, "La gouvernance des jeunes entreprises innovantes:un éclairage analytique à partir du cas des sociétés de biotechnologies," Revue Finance Contrôle Stratégie, revues.org, volume 7, issue 2, pages 67-94, June.
• Tomofumi & Anegawa, 2004, "Price Regulation and Competition in Japanese Pharmaceutical Market," Econometric Society 2004 Far Eastern Meetings, Econometric Society, number 481, Aug.
• Andrew Ching, 2004, "A Dynamic Oligopoly Structural Model for the Prescription Drug Market After Patent Expiration," Econometric Society 2004 Far Eastern Meetings, Econometric Society, number 735, Aug.
• Gilsing, V. & Nooteboom, B., 2004, "Density and strength of ties in innovation networks: an analysis of multimedia and biotechnology," Working Papers, Eindhoven Center for Innovation Studies, number 04.16.
• G. Buenstorf & S. Klepper, 2004, "The Origin and Location of Entrants in the Evolution of the U.S. Tire Industry," Papers on Economics and Evolution, Philipps University Marburg, Department of Geography, number 2004-07, May.
• Marc-Hubert Depret & Abdellilah Hamdouch, 2004, "La gouvernance des jeunes entreprises innovantes : un éclairage analytique à partir du cas des sociétés de biotechnologies," Post-Print, HAL, number halshs-00006702.
• Razzolini, Tiziano, 2004, "The Norwegian market for pharmaceuticals and the non-mandatory substitution reform of 2001: the case of enalapril," Memorandum, Oslo University, Department of Economics, number 12/2004, Oct.
• Eliasson, Gunnar & Eliasson, Åsa, 2004, "Competence in Health Care - An Industrial Systems Analysis Using Competence Bloc Theory to Compare European and US Health Care," Ratio Working Papers, The Ratio Institute, number 46, May.
• Reisinger, Markus, 2004, "Vertical Product Differentiation, Market Entry, and Welfare," Discussion Papers in Economics, University of Munich, Department of Economics, number 479, Dec.
• Ernst R. Berndt & Adrian H. B. Gottschalk & Tomas Philipson & Matthew W. Strobeck, 2004, "Assessing the Impacts of the Prescription Drug User Fee Acts (PDUFA) on the FDA Approval Process," NBER Working Papers, National Bureau of Economic Research, Inc, number 10822, Oct.
• Frank R. Lichtenberg, 2004, "The Effect of Drug Vintage on Survival: Micro Evidence from Puerto Rico's Medicaid Program," NBER Working Papers, National Bureau of Economic Research, Inc, number 10884, Nov.
• Steven N. Wiggins & Robert Maness, 2004, "Price Competition in Pharmaceuticals: The Case of Anti-infectives," Economic Inquiry, Western Economic Association International, volume 42, issue 2, pages 247-263, April.
• Yamasaki, Kazuko & Matia, Kaushik & Buldyrev, Sergey V. & Fu, Dongfeng & Pammolli, Fabio & Riccaboni, Massimo & Stanley, H. Eugene, 2004, "Preferential attachment and growth dynamics in complex systems," MPRA Paper, University Library of Munich, Germany, number 15908, Jun, revised 06 Feb 2006.
• Magazzini, Laura & Pammolli, Fabio & Riccaboni, Massimo, 2004, "Dynamic Competition in Pharmaceuticals: Patent Expiry, Generic Penetration, and Industry Structure," MPRA Paper, University Library of Munich, Germany, number 15968, Feb.
• Pammolli, Fabio & Riccaboni, Massimo, 2004, "Market Structure and Drug Innovation," MPRA Paper, University Library of Munich, Germany, number 16212.
• Pradhan, Jaya Prakash, 2004, "FDI spillovers and local productivity growth: evidence from Indian pharmaceutical industry," MPRA Paper, University Library of Munich, Germany, number 17080, Jul.
• Tyabji, Nasir, 2004, "Gaining Technical Know-How in an Unequal World: Penicillin Manufacture in Nehru's India," MPRA Paper, University Library of Munich, Germany, number 84236, Apr.
• Christine de Mazières & Valérie Paris, 2004, "La régulation de l’industrie pharmaceutique," Revue d'Économie Financière, Programme National Persée, volume 76, issue 3, pages 241-265, DOI: 10.3406/ecofi.2004.4924.
• Pablo D'Este Cukierman, 2004, "Persistent Knowledge Specialisation and Intra-Industry Heterogeneity: an Analysis of the Spanish Pharmaceutical Industry," SPRU Working Paper Series, SPRU - Science Policy Research Unit, University of Sussex Business School, number 110, Jan.
• Drusilla K. Brown & George Norman, 2004, "Optimal Intellectual Property Rights Protection and Humanitarian Assistance during and International Health Emergency," Discussion Papers Series, Department of Economics, Tufts University, Department of Economics, Tufts University, number 0416.
• María Inés Terra & Gustavo Bittencourt & Rosario Domingo & Carmen Estrades & Gabriel Katz & Alvaro Ons & Héctor Pastori, 2004, "Estudios de competitividad sectoriales. Industria manufacturera," Documentos de Trabajo (working papers), Department of Economics - dECON, number 2305, Oct.
• Joan Costa & Jaume Puig, 2004, "Regulatory ambivalence and the limitations of pharmaceutical policy in Spain," Economics Working Papers, Department of Economics and Business, Universitat Pompeu Fabra, number 762, Jun.
• Joan Costa & Jaume Puig, 2004, "Regulatory ambivalence and the limitations of pharmaceutical policy in Spain," Working Papers, Research Center on Health and Economics, Department of Economics and Business, Universitat Pompeu Fabra, number 762, Jun.
• Dan Marsh, 2004, "Biotechnology in New Zealand," Working Papers in Economics, University of Waikato, number 04/01, Sep.

2003

• Lori D. Snyder & Nolan H. Miller & Robert N. Stavins, 2003, "The Effects of Environmental Regulation on Technology Diffusion: The Case of Chlorine Manufacturing," American Economic Review, American Economic Association, volume 93, issue 2, pages 431-435, May.
• Snyder, Lori D. & Miller, Nolan & Stavins, Robert N., 2003, "The Effects of Environmental Regulation On Technology Diffusion: The Case of Chlorine Manufacturing," Discussion Papers, Resources for the Future, number 10554, DOI: 10.22004/ag.econ.10554.
• Antonio Cabrales, 2015, "Pharmaceutical Generics, Vertical Product Differentiation, and Public Policy," Working Papers, Barcelona School of Economics, number 54, Sep.
• Ernst R. Berndt & Robert S. Pindyck & Pierre Azoulay, 2003, "Consumption Externalities and Diffusion in Pharmaceutical Markets: Antiulcer Drugs," Journal of Industrial Economics, Wiley Blackwell, volume 51, issue 2, pages 243-270, June, DOI: 10.1111/1467-6451.00200.
• Sanoussi Bilal & Jean‐Marie Grether & Jaime de Melo, 2003, "Attitudes Towards Immigration: a Trade‐Theoretic Approach," Review of International Economics, Wiley Blackwell, volume 11, issue 2, pages 253-267, May, DOI: 10.1111/1467-9396.00381.
• Christel Lane & Jocelyn Probert, 2003, "Globalisation and Its Impact on Competitiveness: the Case of the British and German Pharmaceutical Industry," Working Papers, Centre for Business Research, University of Cambridge, number wp262, Jun.
• Thomas Röhm, 2003, "Die Bedeutung von Patentschutz für den Technologietransfer in Entwicklungsländer : Erfahrungen der chemischen Industrie in Südkorea, Malaysia und Chile im Vergleich," ifo Beiträge zur Wirtschaftsforschung, ifo Institute - Leibniz Institute for Economic Research at the University of Munich, number 12, July.
• Andrea Gebauer & Chang Woon Nam & Rüdiger Parsche & Doina Radulescu & Bettina Reichl, 2002, "Possibilities and Risks of the Introduction of Cross-border Input VAT Deduction System in the EU," ifo Forschungsberichte, ifo Institute - Leibniz Institute for Economic Research at the University of Munich, number 12.
• Jean O Lanjouw, 2003, "The Introduction of Pharmaceutical Product Patents in India: Heartless Exploitation of the Poor and Suffering?," Levine's Working Paper Archive, David K. Levine, number 618897000000000598, Oct.
• Snyder, Lori & Miller, Nolan & Stavins, Robert, 2003, "The Effects of Environmental Regulation on Technology Diffusion: The Case of Chlorine Manufacturing," Working Paper Series, Harvard University, John F. Kennedy School of Government, number rwp03-014, Mar.
• Cadot, Olivier & de Melo, Jaime & Olarreaga, Marcelo, 2003, "The protectionist bias of duty drawbacks: evidence from Mercosur," Journal of International Economics, Elsevier, volume 59, issue 1, pages 161-182, January.
• De Fabritiis, G. & Pammolli, F. & Riccaboni, M., 2003, "On size and growth of business firms," Physica A: Statistical Mechanics and its Applications, Elsevier, volume 324, issue 1, pages 38-44, DOI: 10.1016/S0378-4371(03)00043-8.
• Lori Snyder & Nolan Miller & Robert Stavins, 2003, "The Effects of Environmental Regulation on Technology Diffusion: The Case of Chlorine Manufacturing," Working Papers, Fondazione Eni Enrico Mattei, number 2003.48, Jun.
• Brekke, Kurt R. & Kuhn, Michael, 2003, "Direct-to-Consumer Advertising in Pharmaceutical Markets," Working Papers in Economics, University of Bergen, Department of Economics, number 05/03, Mar.
• Fridh, Ann-Charlotte, 2003, "Titanium Implants – A Comparison of a Swedish and an Ohio Firm," Ratio Working Papers, The Ratio Institute, number 21, Apr.
• Hellström, Jörgen & Rudholm, Niklas, 2003, "Uncertainty in the Generic Versus Brand Name Prescription Decision," Umeå Economic Studies, Umeå University, Department of Economics, number 602, Jan.
• Jorge Mestre, 2003, "Reference prices: The Spanish way," Investigaciones Economicas, Fundación SEPI, volume 27, issue 1, pages 125-149, January.
• Michael Dickson & Stephane Jacobzone, 2003, "Pharmaceutical Use and Expenditure for Cardiovascular Disease and Stroke: A Study of 12 OECD Countries," OECD Health Working Papers, OECD Publishing, number 1, Feb, DOI: 10.1787/237273475872.
• Professor Tony VanDuzer, 2003, "TRIPS and the Pharmaceutical Industry in Bangladesh: Towards a National Strategy," CPD Working Paper, Centre for Policy Dialogue (CPD), number 24, Apr.
• De Fabritiis, Gianni & Riccaboni, Massimo & Pammolli, Fabio, 2003, "On Size and Growth of Business Firms," MPRA Paper, University Library of Munich, Germany, number 15866, Mar.
• Pradhan, Jaya Prakash, 2003, "Liberalization, Firm Size and R&D performance: A Firm Level Study of Indian Pharmaceutical Industry," MPRA Paper, University Library of Munich, Germany, number 17079, Jul.
• Allen, Thomas & Gabe, Todd, 2003, "The economic impact of Biotechnology in New England," MPRA Paper, University Library of Munich, Germany, number 65984, Nov.
• Stavins, Robert & Snyder, Lori & Miller, Nolan, 2003, "The Effects of Environmental Regulation On Technology Diffusion: The Case of Chlorine Manufacturing," RFF Working Paper Series, Resources for the Future, number dp-03-25, Aug.
• Paola Criscuolo, 2003, "Reverse Technology Transfer: A Patent Citation Analysis of the European Chemical and Pharmaceutical Sectors," SPRU Working Paper Series, SPRU - Science Policy Research Unit, University of Sussex Business School, number 107, Oct.
• Lionel Nesta & Pier-Paolo Saviotti, 2003, "Intangible Assests and Market Value: Evidence from Biotechnology Firms," SPRU Working Paper Series, SPRU - Science Policy Research Unit, University of Sussex Business School, number 87, Jun.
• Stefano Brusoni & Paola Criscuolo & Aldo Geuna, 2003, "The Knowledge Bases of the World's Largest Pharmaceuticals Groups: what do Patent Citations to Non-Patent Literature Reveal?," SPRU Working Paper Series, SPRU - Science Policy Research Unit, University of Sussex Business School, number 90, Jun.
• Andreas Pyka & Paul Windrum, 2003, "The self-organisation of strategic alliances," Economics of Innovation and New Technology, Taylor & Francis Journals, volume 12, issue 3, pages 245-268, DOI: 10.1080/10438590290025561.
• Drusilla K. Brown & George Norman, 2003, "Optimal Intellectual Property Rights Exhaustion and Humanitarian Assistance during a National Health Emergency," Discussion Papers Series, Department of Economics, Tufts University, Department of Economics, Tufts University, number 0314.
• Lynda Oswald & Valerie Suslow & Margaret Levenstein & Manuel Pastor, 2003, "International Price-Fixing Cartels and Developing Countries: A Discussion of Effects and Policy Remedies," Working Papers, Political Economy Research Institute, University of Massachusetts at Amherst, number wp53.
• Antonio Cabrales, 2003, "Pharmaceutical generics, vertical product differentiation and public policy," Economics Working Papers, Department of Economics and Business, Universitat Pompeu Fabra, number 662, Jan.
• Antonio Cabrales, 2003, "Pharmaceutical generics, vertical product differentiation and public policy," Working Papers, Research Center on Health and Economics, Department of Economics and Business, Universitat Pompeu Fabra, number 662, Jan.
• Margaret Levenstein & Valerie Suslow & Lynda Oswald, 2003, "International Price-Fixing Cartels and Developing Countries: A Discussion of Effects and Policy Remedies," William Davidson Institute Working Papers Series, William Davidson Institute at the University of Michigan, number 538, Feb.
• Uwe Dulleck & Neil Foster-McGregor & Doris Hanzl-Weiss & Zdenek Lukas & Josef Pöschl & Robert Stehrer & Julia Wörz, 2003, "wiiw Structural Report 2003 on Central and Eastern Europe, Volume 3," wiiw Structural Report, The Vienna Institute for International Economic Studies, wiiw, number 3, Oct.
• Neunteufel, Herbert & Rössel, Gottfried & Sassenberg, Uwe, 2003, "Das Marketingniveau in der Kunststoffbranche Westmecklenburgs," Wismar Discussion Papers, Hochschule Wismar, Wismar Business School, number 06/2003.

2002

• Castellini, Alessandra & Canavari, Maurizio & Pirazzoli, Carlo, 2002, "Functional Foods In The European Union: An Overview Of The Sector'S Main Issues," Working Papers, University of Minnesota, Center for International Food and Agricultural Policy, number 14456, DOI: 10.22004/ag.econ.14456.
• Jean-François BRUN & Céline CARRERE & Jaime MELO DE & Patrick GUILLAUMONT, 2002, "Has Distance Died? Evidence from a Panel Gravity Model," Working Papers, CERDI, number 200215.